Picture [LSUS] – The Business Web Portal 600x60px
Document › Details

Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge.

Region Region London, Greater London
  Country United Kingdom (GB)
Organisations Organisation Novacyt S.A. (Alternext: ALNOV)
  Group Novacyt (Group)
  Organisation 2 Stifel Nicolaus Europe Ltd.
  Group Stifel (Group)
Products Product investment banking
Index term Index term Novacyt–SEVERAL: investment, 201710 capital increase €9.7m with 14.74m new shares at €0.66/share
Persons Person Mullis, Graham (Novacyt 201409 CEO before Lab21 CEO)
  Person 2 Dyer, Anthony (Novacyt 201409– Finance Director before part time Group Financial Controller)

Record changed: 2017-10-30


Picture [LSA] – The Business Web Portal 650x89px

More documents for Novacyt (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top